The following trials provide information to treat various types of respiratory and inflammatory diseases, both for ongoing and completed clinical trials. For more information on both of these therapy areas please click here.
- collapse An Open-Label. Phase I Study to Assess the Excretion of Radioactivity, Metabolic Profiles and Pharmacokinetics folloiwing a Single Oral Dose of 60 mg of [14C] AZD1236 in Healthy Male Subjects
- collapse A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Phase II study to Assess the Efficacy of 28 Day Oral Administration of AZD1236 in Adult Patients with Cystic Fibrosis
- collapse An Open-Label, Non-Randomized, 2-Period, Single Center Study to Assess the Single Dose Pharmacokinetics of R406 in Healthy Subjects when Fostamatinib 150 mg is Administered Alone and in Combination with Rifampicin
- collapse A Study of Fostamatinib in Subjects With Impaired Hepatic (Liver) Function
- collapse Study to Investigate the Impact of Dose and Dosing Frequency of AZD8848 on the Response on Biomarkers
- collapse Phase I, open label, healthy volunteers, ADME study with single oral administration of [14C] AZD5069
- collapse A Phase I, Open Label, Randomised, 4-way Crossover Study to Investigate the Relative Bioavailability of Single Dose AZD1981 via 3 Different Tablets in Healthy Men and Healthy Women of Non-childbearing Potential
- collapse The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD) (Cricket)
- collapse A Drug-Drug Interaction Study Between AZD1981 and Pravastatin to Study the Effect of AZD1981 on the Kinetics of Pravastatin
- collapse Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled AZD5423 after Administration of Multiple Ascending Doses for 14 days in Healthy Male and Female Subjects
